Neoadjuvant Docetaxel in Treating Women With Newly Diagnosed Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: BIOLOGICAL: pegfilgrastim|DRUG: docetaxel|PROCEDURE: conventional surgery|PROCEDURE: neoadjuvant therapy
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Collaborators: National Cancer Institute (NCI)